1	Sterol	Sterol	_	_	_	_	_	_	_
2	dependent	dependent	_	_	_	_	_	_	_
3	LDL-receptor	LDL-receptor	_	_	_	_	_	_	_
4	gene	gene	_	_	_	_	_	_	_
5	transcription	transcription	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	from	from	_	_	_	_	_	_	_
9	normal	normal	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	CML	CML	_	_	_	_	_	_	_
12	patients	patient	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Sterol	Sterol	_	_	_	_	_	_	_
2	regulatory	regulatory	_	_	_	_	_	_	_
3	element	element	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	SRE	SRE	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	has	have	_	_	_	_	_	_	_
8	been	be	_	_	_	_	_	_	_
9	recognized	recognize	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	regulate	regulate	_	_	_	_	_	_	_
12	various	various	_	_	_	_	_	_	_
13	key	key	_	_	_	_	_	_	_
14	genes	gene	_	_	_	_	_	_	_
15	coding	cod	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	especially	especially	_	_	_	_	_	_	_
18	low	low	_	_	_	_	_	_	_
19	density	density	_	_	_	_	_	_	_
20	lipoprotein	lipoprotein	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	LDL)-receptor	LDL)-receptor	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	3-hydroxy-3-methylglutaryl	3-hydroxy-3-methylglutaryl	_	_	_	_	_	_	_
25	coenzyme	coenzyme	_	_	_	_	_	_	_
26	A	A	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	HMG-CoA	HMG-CoA	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	reductase	reductase	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	HMG-CoA	HMG-CoA	_	_	_	_	_	_	_
33	synthase	synthase	_	_	_	_	_	_	_
34	known	know	_	_	_	_	_	_	_
35	to	to	_	_	_	_	_	_	_
36	play	play	_	_	_	_	_	_	_
37	a	a	_	_	_	_	_	_	_
38	crucial	crucial	_	_	_	_	_	_	_
39	role	role	_	_	_	_	_	_	_
40	in	in	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	cholesterol	cholesterol	_	_	_	_	_	_	_
43	feedback	feedback	_	_	_	_	_	_	_
44	mechanism	mechanism	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	deranged	derange	_	_	_	_	_	_	_
3	cholesterol	cholesterol	_	_	_	_	_	_	_
4	feedback	feedback	_	_	_	_	_	_	_
5	mechanism	mechanism	_	_	_	_	_	_	_
6	has	have	_	_	_	_	_	_	_
7	been	be	_	_	_	_	_	_	_
8	widely	widely	_	_	_	_	_	_	_
9	recognised	recognise	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	initiation	initiation	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	well	well	_	_	_	_	_	_	_
14	as	as	_	_	_	_	_	_	_
15	progression	progression	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	various	various	_	_	_	_	_	_	_
18	types	type	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	cancers	cancer	_	_	_	_	_	_	_
21	including	include	_	_	_	_	_	_	_
22	chronic	chronic	_	_	_	_	_	_	_
23	myeloid	myeloid	_	_	_	_	_	_	_
24	leukaemia	leukaemia	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	CML	CML	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Consequently	consequently	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	present	present	_	_	_	_	_	_	_
5	study	study	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	addressed	address	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	understand	understand	_	_	_	_	_	_	_
10	this	this	_	_	_	_	_	_	_
11	phenomenon	phenomenon	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	revealed	reveal	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	existence	existence	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	unique	unique	_	_	_	_	_	_	_
19	47	47	_	_	_	_	_	_	_
20	kDa	kda	_	_	_	_	_	_	_
21	protein	protein	_	_	_	_	_	_	_
22	factor	factor	_	_	_	_	_	_	_
23	having	have	_	_	_	_	_	_	_
24	affinity	affinity	_	_	_	_	_	_	_
25	for	for	_	_	_	_	_	_	_
26	this	this	_	_	_	_	_	_	_
27	SRE	SRE	_	_	_	_	_	_	_
28	sequence	sequence	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	lymphocytes	lymphocyte	_	_	_	_	_	_	_
31	from	from	_	_	_	_	_	_	_
32	normal	normal	_	_	_	_	_	_	_
33	subjects	subject	_	_	_	_	_	_	_
34	as	as	_	_	_	_	_	_	_
35	well	well	_	_	_	_	_	_	_
36	as	as	_	_	_	_	_	_	_
37	its	its	_	_	_	_	_	_	_
38	absence	absence	_	_	_	_	_	_	_
39	in	in	_	_	_	_	_	_	_
40	lymphocytes	lymphocyte	_	_	_	_	_	_	_
41	from	from	_	_	_	_	_	_	_
42	untreated	untreated	_	_	_	_	_	_	_
43	CML	CML	_	_	_	_	_	_	_
44	patients	patient	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	factor	factor	_	_	_	_	_	_	_
5	appeared	appear	_	_	_	_	_	_	_
6	when	when	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	CML	CML	_	_	_	_	_	_	_
9	patients	patient	_	_	_	_	_	_	_
10	achieved	achieve	_	_	_	_	_	_	_
11	complete	complete	_	_	_	_	_	_	_
12	haematological	haematological	_	_	_	_	_	_	_
13	remission	remission	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	CHR	CHR	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	through	through	_	_	_	_	_	_	_
18	alpha-interferon	alpha-interferon	_	_	_	_	_	_	_
19	therapy	therapy	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Further	further	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	an	an	_	_	_	_	_	_	_
4	inverse	inverse	_	_	_	_	_	_	_
5	relationship	relationship	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	also	also	_	_	_	_	_	_	_
8	observed	observe	_	_	_	_	_	_	_
9	between	between	_	_	_	_	_	_	_
10	sterol	sterol	_	_	_	_	_	_	_
11	modulated	modulate	_	_	_	_	_	_	_
12	LDL-receptor	LDL-receptor	_	_	_	_	_	_	_
13	gene	gene	_	_	_	_	_	_	_
14	transcription	transcription	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	binding	binding	_	_	_	_	_	_	_
18	affinity	affinity	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	this	this	_	_	_	_	_	_	_
21	47	47	_	_	_	_	_	_	_
22	kDa	kda	_	_	_	_	_	_	_
23	factor	factor	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	SRE	SRE	_	_	_	_	_	_	_
27	sequence	sequence	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Based	base	_	_	_	_	_	_	_
2	upon	upon	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	propose	propose	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	alpha-interferon	alpha-interferon	_	_	_	_	_	_	_
9	through	through	_	_	_	_	_	_	_
10	its	its	_	_	_	_	_	_	_
11	receptor	receptor	_	_	_	_	_	_	_
12	initiates	initiate	_	_	_	_	_	_	_
13	phosphatidic	phosphatidic	_	_	_	_	_	_	_
14	acid	acid	_	_	_	_	_	_	_
15	dependent	dependent	_	_	_	_	_	_	_
16	signalling	signalling	_	_	_	_	_	_	_
17	which	which	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	turn	turn	_	_	_	_	_	_	_
20	regulates	regulate	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	affinity	affinity	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	47	47	_	_	_	_	_	_	_
25	kDa	kda	_	_	_	_	_	_	_
26	sterol	sterol	_	_	_	_	_	_	_
27	regulatory	regulatory	_	_	_	_	_	_	_
28	element	element	_	_	_	_	_	_	_
29	binding	binding	_	_	_	_	_	_	_
30	factor	factor	_	_	_	_	_	_	_
31	as	as	_	_	_	_	_	_	_
32	well	well	_	_	_	_	_	_	_
33	as	as	_	_	_	_	_	_	_
34	LDL-receptor	LDL-receptor	_	_	_	_	_	_	_
35	gene	gene	_	_	_	_	_	_	_
36	transcription	transcription	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	lymphocytes	lymphocyte	_	_	_	_	_	_	_
39	from	from	_	_	_	_	_	_	_
40	CML	CML	_	_	_	_	_	_	_
41	patients	patient	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

